Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands.
Transpl Int. 2021 Apr;34(4):657-668. doi: 10.1111/tri.13845. Epub 2021 Mar 1.
With a later onset of diabetes complications and thus increasing age of transplant candidates, many centers have extended upper age limits for pancreas transplantation. This study investigates the effect of recipient and donor age on outcomes after pancreas transplantation.We retrospectively analyzed 565 pancreas transplants performed at two Eurotransplant centers. The cohort was split at a recipient and donor age of 50 and 40 years, respectively. Median recipient age in old patients (≥50 years; 27.2%) was 54 years and 40 years in young patients (<50 years). Compared to young recipients, old recipients had an inferior patient survival rate (≥50: 5yr, 82.8%; 10yr, 65.6%; <50: 5yr, 93.3%; 10yr, 82.0%; P < 0.0001). Old recipients demonstrated comparable death-censored pancreas (≥50: 1yr, 80.6%; 5yr, 70.2%; <50: 1yr, 87.3%; 5yr, 77.8%; P = 0.35) and kidney graft survival (≥50: 1yr, 97.4%; 5yr, 90.6%; <50: 1yr, 97.8%; 5yr, 90.2%; P = 0.53) compared to young recipients. Besides a lower rate of kidney rejection, similar relative risks for postoperative complications were detected in old and young patients. This study shows that despite an increased mortality in old recipients, excellent graft survival can be achieved similar to that of young patients. Age alone should not exclude patients from receiving a pancreas transplant.
随着糖尿病并发症发病时间的延迟和移植候选人年龄的增长,许多中心已经延长了胰腺移植的年龄上限。本研究调查了受体和供体年龄对胰腺移植后结果的影响。
我们回顾性分析了在两个 Eurotransplant 中心进行的 565 例胰腺移植。该队列分别在受体和供体年龄为 50 岁和 40 岁时进行了划分。老年患者(≥50 岁;27.2%)的中位受体年龄为 54 岁,年轻患者(<50 岁)的中位受体年龄为 40 岁。与年轻受者相比,老年受者的患者生存率较低(≥50:5 年,82.8%;10 年,65.6%;<50:5 年,93.3%;10 年,82.0%;P<0.0001)。老年受者的死亡相关胰腺(≥50:1 年,80.6%;5 年,70.2%;<50:1 年,87.3%;5 年,77.8%;P=0.35)和肾脏移植物存活率(≥50:1 年,97.4%;5 年,90.6%;<50:1 年,97.8%;5 年,90.2%;P=0.53)与年轻受者相当。除了肾脏排斥率较低外,老年和年轻患者术后并发症的相对风险相似。本研究表明,尽管老年受者的死亡率较高,但仍可获得与年轻受者相似的优秀移植物存活率。年龄本身不应排除患者接受胰腺移植。